Michael Flentje

17.3k total citations
370 papers, 11.7k citations indexed

About

Michael Flentje is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Flentje has authored 370 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Pulmonary and Respiratory Medicine, 143 papers in Radiation and 127 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Flentje's work include Advanced Radiotherapy Techniques (141 papers), Medical Imaging Techniques and Applications (63 papers) and Lung Cancer Diagnosis and Treatment (56 papers). Michael Flentje is often cited by papers focused on Advanced Radiotherapy Techniques (141 papers), Medical Imaging Techniques and Applications (63 papers) and Lung Cancer Diagnosis and Treatment (56 papers). Michael Flentje collaborates with scholars based in Germany, Switzerland and United States. Michael Flentje's co-authors include Matthias Gückenberger, Kurt Baier, Jürgen Wilbert, Anne Richter, Dirk Vordermark, Ulrich Oppitz, Gerd Mueller, Joern Wulf, Juergen Meyer and Thomas Krieger and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Michael Flentje

361 papers receiving 11.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Flentje 5.3k 5.2k 4.5k 2.4k 1.9k 370 11.7k
Mitchell S. Anscher 3.4k 0.6× 6.6k 1.3× 5.0k 1.1× 2.5k 1.1× 2.4k 1.2× 268 12.8k
Frederik Wenz 4.8k 0.9× 4.7k 0.9× 5.1k 1.1× 2.1k 0.9× 2.7k 1.4× 508 13.2k
Susan L. Tucker 5.5k 1.1× 7.5k 1.4× 4.7k 1.0× 2.8k 1.2× 4.2k 2.1× 224 16.1k
Howard D. Thames 5.0k 0.9× 8.6k 1.7× 5.3k 1.2× 2.9k 1.2× 3.2k 1.6× 298 16.4k
Yuta Shibamoto 2.3k 0.4× 5.5k 1.1× 2.6k 0.6× 2.4k 1.0× 2.4k 1.2× 563 11.2k
Guy Storme 4.1k 0.8× 6.0k 1.1× 2.9k 0.6× 1.7k 0.7× 2.2k 1.1× 255 10.8k
Joe Y. Chang 5.8k 1.1× 9.9k 1.9× 4.5k 1.0× 1.8k 0.8× 3.9k 2.0× 353 14.0k
Volker Budach 2.1k 0.4× 4.6k 0.9× 2.3k 0.5× 2.6k 1.1× 3.5k 1.8× 395 12.3k
H. Rodney Withers 2.4k 0.4× 4.2k 0.8× 4.2k 0.9× 1.7k 0.7× 2.4k 1.2× 184 10.2k
M. Molls 1.7k 0.3× 3.7k 0.7× 3.1k 0.7× 1.7k 0.7× 1.7k 0.9× 318 9.8k

Countries citing papers authored by Michael Flentje

Since Specialization
Citations

This map shows the geographic impact of Michael Flentje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Flentje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Flentje more than expected).

Fields of papers citing papers by Michael Flentje

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Flentje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Flentje. The network helps show where Michael Flentje may publish in the future.

Co-authorship network of co-authors of Michael Flentje

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Flentje. A scholar is included among the top collaborators of Michael Flentje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Flentje. Michael Flentje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Polat, Bülent, Gisela Wohlleben, Frederick Mantel, et al.. (2022). Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma. Cancer Cell International. 22(1). 87–87. 11 indexed citations
6.
Shelan, Mohamed, Daniel M. Aebersold, Dirk Böhmer, et al.. (2021). Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries. Strahlentherapie und Onkologie. 197(11). 993–1000. 4 indexed citations
8.
Pinkawa, Michael, Daniel M. Aebersold, Dirk Böhmer, et al.. (2021). Radiotherapy in nodal oligorecurrent prostate cancer. Strahlentherapie und Onkologie. 197(7). 575–580. 9 indexed citations
9.
Hartrampf, Philipp E., Heribert Hänscheid, Olivia Kertels, et al.. (2020). Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma. Clinical and Translational Radiation Oncology. 22. 29–32. 31 indexed citations
10.
Fokas, Emmanouil, Michael Flentje, Rolf Sauer, et al.. (2020). Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial. European Journal of Cancer. 144. 281–290. 13 indexed citations
12.
Wohlleben, Gisela, et al.. (2017). Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma. Oncology Reports. 39(1). 442–448. 14 indexed citations
13.
Wohlleben, Gisela, Agmal Scherzad, Antje Güttler, et al.. (2015). Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines. Radiation Oncology. 10(1). 167–167. 14 indexed citations
14.
Boda‐Heggemann, Judit, Frank Lohr, Frederik Wenz, Michael Flentje, & Matthias Gückenberger. (2011). kV Cone-Beam CT-Based IGRT. Strahlentherapie und Onkologie. 187(5). 284–291. 160 indexed citations
15.
Sauer, Rolf, et al.. (2008). Multimodale Therapie des Rektumkarzinoms. Onkologie. 31(5). 24–28. 1 indexed citations
16.
Vordermark, Dirk, Klemens Ruprecht, Peter Rieckmann, et al.. (2006). Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). BMC Cancer. 6(1). 247–247. 36 indexed citations
17.
Wiegel, Thomas, Alessandra Siegmann, Julian Willner, et al.. (2004). A Multicenter Analysis of 123 Patients with Recurrent Rectal Cancer within the Pelvis. Frontiers of radiation therapy and oncology. 38. 41–51. 1 indexed citations
18.
Kölbl, Oliver, et al.. (1997). Das lokoregionäre Rezidiv des Rektumkarzinoms: Eine computertomographische Analyse und ein Zielvolumenkonzept für die adjuvante Radiotherapie. Strahlentherapie und Onkologie. 173(2). 68–75. 7 indexed citations
19.
20.
Schraube, P., Michael Flentje, & M. Wannenmacher. (1994). Tangential breast irradiation: comparison of patient positioning and beam parameters after planning investigation at a CT scanner and a simulator with CT option.. PubMed. 170(2). 107–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026